KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Total Non-Current Liabilities (2017 - 2026)

Guardant Health's Total Non-Current Liabilities history spans 9 years, with the latest figure at $2.0 billion for Q4 2025.

  • On a quarterly basis, Total Non-Current Liabilities rose 29.55% to $2.0 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $2.0 billion, a 29.55% increase, with the full-year FY2025 number at $2.0 billion, up 29.55% from a year prior.
  • Total Non-Current Liabilities hit $2.0 billion in Q4 2025 for Guardant Health, up from $1.5 billion in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for GH hit a ceiling of $2.0 billion in Q4 2025 and a floor of $1.4 billion in Q1 2021.
  • Historically, Total Non-Current Liabilities has averaged $1.5 billion across 5 years, with a median of $1.5 billion in 2024.
  • Biggest five-year swings in Total Non-Current Liabilities: surged 1201.66% in 2021 and later dropped 3.17% in 2024.
  • Tracing GH's Total Non-Current Liabilities over 5 years: stood at $1.6 billion in 2021, then fell by 0.96% to $1.5 billion in 2022, then decreased by 0.58% to $1.5 billion in 2023, then grew by 0.05% to $1.5 billion in 2024, then increased by 29.55% to $2.0 billion in 2025.
  • Business Quant data shows Total Non-Current Liabilities for GH at $2.0 billion in Q4 2025, $1.5 billion in Q3 2025, and $1.5 billion in Q2 2025.